Glucocorticoid Signaling Pathway

Glucocorticoids (e.g., cortisol, prednisone, dexamethasone) exert their effects primarily through intracellular receptor-mediated gene regulation.

They influence metabolism, immune response, and inflammation.

See drug class:


Step 1 – Cell Entry

Glucocorticoids are lipid-soluble.


Step 2 – Cytoplasmic Receptor Binding

Inside the cytoplasm:

Now activated GR–steroid complex forms.


Step 3 – Nuclear Translocation

The activated glucocorticoid-receptor complex:

This alters gene transcription.


Genomic Effects

Upregulated (Anti-Inflammatory Genes)

Downregulated (Pro-Inflammatory Genes)

Net effect:

↓ Inflammation
↓ Immune cell activation
↓ Eosinophil survival

Onset:

Hours to days (requires gene transcription)

Non-Genomic Effects

Some rapid effects occur within minutes.

Mechanisms may include:

These effects are less well defined but clinically relevant in acute settings.


Inflammatory Pathway Suppression

Key downstream effect:

↓ Phospholipase A2 activity
↓ Arachidonic acid production
↓ Prostaglandins
↓ Leukotrienes

This explains synergy with:


Immune System Impact

Glucocorticoids:

Clinical implication:

Broad immunosuppression.

Metabolic Effects

Glucocorticoids also:

Explains:


HPA Axis Regulation

Endogenous cortisol secretion is regulated by:

Hypothalamus → CRH  
Pituitary → ACTH  
Adrenal cortex → Cortisol  

Cortisol provides negative feedback at hypothalamus and pituitary.

Exogenous glucocorticoids suppress ACTH production → adrenal atrophy.

See:


Clinical Integration

Glucocorticoid signaling explains therapeutic use in:


High-Yield Pearls